AMPH
Price
$26.85
Change
+$0.49 (+1.86%)
Updated
Sep 26 closing price
Capitalization
1.25B
43 days until earnings call
RDHL
Price
$1.84
Change
+$0.19 (+11.52%)
Updated
Sep 26 closing price
Capitalization
6.13M
65 days until earnings call
Interact to see
Advertisement

AMPH vs RDHL

Header iconAMPH vs RDHL Comparison
Open Charts AMPH vs RDHLBanner chart's image
Amphastar Pharmaceuticals
Price$26.85
Change+$0.49 (+1.86%)
Volume$291.26K
Capitalization1.25B
Redhill Biopharma
Price$1.84
Change+$0.19 (+11.52%)
Volume$150.81K
Capitalization6.13M
AMPH vs RDHL Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. RDHL commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and RDHL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AMPH: $26.85 vs. RDHL: $1.84)
Brand notoriety: AMPH and RDHL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 54% vs. RDHL: 148%
Market capitalization -- AMPH: $1.25B vs. RDHL: $6.13M
AMPH [@Pharmaceuticals: Generic] is valued at $1.25B. RDHL’s [@Pharmaceuticals: Generic] market capitalization is $6.13M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, AMPH is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while RDHL’s TA Score has 5 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 4 bearish.
  • RDHL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMPH and RDHL are a good buy in the short-term.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -2.86% price change this week, while RDHL (@Pharmaceuticals: Generic) price change was +8.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

RDHL is expected to report earnings on Dec 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($1.25B) has a higher market cap than RDHL($6.13M). AMPH has higher P/E ratio than RDHL: AMPH (10.06) vs RDHL (0.09). AMPH YTD gains are higher at: -27.687 vs. RDHL (-70.370). AMPH has more cash in the bank: 232M vs. RDHL (13.3M). RDHL has less debt than AMPH: RDHL (2.28M) vs AMPH (655M).
AMPHRDHLAMPH / RDHL
Capitalization1.25B6.13M20,369%
EBITDA248MN/A-
Gain YTD-27.687-70.37039%
P/E Ratio10.060.0911,666%
Revenue723MN/A-
Total Cash232M13.3M1,744%
Total Debt655M2.28M28,678%
FUNDAMENTALS RATINGS
AMPH vs RDHL: Fundamental Ratings
AMPH
RDHL
OUTLOOK RATING
1..100
7493
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
48100
PRICE GROWTH RATING
1..100
6357
P/E GROWTH RATING
1..100
8577
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (67) in the Pharmaceuticals Other industry is in the same range as RDHL (90) in the Biotechnology industry. This means that AMPH’s stock grew similarly to RDHL’s over the last 12 months.

AMPH's Profit vs Risk Rating (87) in the Pharmaceuticals Other industry is in the same range as RDHL (100) in the Biotechnology industry. This means that AMPH’s stock grew similarly to RDHL’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for RDHL (100) in the Biotechnology industry. This means that AMPH’s stock grew somewhat faster than RDHL’s over the last 12 months.

RDHL's Price Growth Rating (57) in the Biotechnology industry is in the same range as AMPH (63) in the Pharmaceuticals Other industry. This means that RDHL’s stock grew similarly to AMPH’s over the last 12 months.

RDHL's P/E Growth Rating (77) in the Biotechnology industry is in the same range as AMPH (85) in the Pharmaceuticals Other industry. This means that RDHL’s stock grew similarly to AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHRDHL
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRON65.553.05
+4.88%
Disc Medicine
H142.112.11
+1.51%
Hyatt Hotels Corp
TSSI17.660.15
+0.86%
TSS.Inc
GLTO4.41-0.04
-0.90%
Galecto Inc
SHIM2.65-0.13
-4.68%
Shimmick Corp

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+1.86%
AMRX - AMPH
34%
Loosely correlated
+1.56%
ZTS - AMPH
33%
Loosely correlated
+1.68%
VTRS - AMPH
29%
Poorly correlated
+0.32%
HROW - AMPH
29%
Poorly correlated
+2.06%
DRRX - AMPH
28%
Poorly correlated
N/A
More

RDHL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDHL has been loosely correlated with ORXOY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RDHL jumps, then ORXOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
+11.52%
ORXOY - RDHL
38%
Loosely correlated
N/A
BFRI - RDHL
23%
Poorly correlated
-0.02%
OGI - RDHL
22%
Poorly correlated
-3.43%
AMPH - RDHL
22%
Poorly correlated
+1.86%
TLRY - RDHL
22%
Poorly correlated
-3.36%
More